Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of completeness of case ascertainment in Swiss cancer registration.
Lorez M, Bordoni A, Bouchardy C, Bulliard JL, Camey B, Dehler S, Frick H, Konzelmann I, Maspoli M, Mousavi SM, Rohrmann S, Arndt V. Lorez M, et al. Eur J Cancer Prev. 2017 Sep;26 Joining forces for better cancer registration in Europe:S139-S146. doi: 10.1097/CEJ.0000000000000380. Eur J Cancer Prev. 2017. PMID: 28574868 Free article.
Comment on: Wiser et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647.
Feller A, Bopp M, Lorez M, Zellweger U, Adam M, Curjuric I, Staehelin K, Perren A, Bergeron Y, Rapiti E, Mousavi M, Diebold J, Dyntar D, Bulliard JL, Maspoli Conconi M, Bordoni A, Konzelmann I, Wagner U, Rohrmann S. Feller A, et al. Among authors: lorez m. Swiss Med Wkly. 2020 Feb 7;150:w20179. doi: 10.4414/smw.2020.20179. eCollection 2020 Jan 27. Swiss Med Wkly. 2020. PMID: 32031233 Free article. No abstract available.
A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland.
Panje CM, Lupatsch JE, Barbier M, Pardo E, Lorez M, Dedes KJ, Aebersold DM, Plasswilm L, Gautschi O, Schwenkglenks M; Swiss Group for Clinical Cancer Research (SAKK). Panje CM, et al. Among authors: lorez m. Ann Oncol. 2020 Apr;31(4):501-506. doi: 10.1016/j.annonc.2020.01.007. Epub 2020 Jan 16. Ann Oncol. 2020. PMID: 32107097 Free article.
The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods.
Rossi S, Baili P, Capocaccia R, Caldora M, Carrani E, Minicozzi P, Pierannunzio D, Santaquilani M, Trama A, Allemani C, Belot A, Buzzoni C, Lorez M, De Angelis R; EUROCARE-5 Working Group:. Rossi S, et al. Among authors: lorez m. Eur J Cancer. 2015 Oct;51(15):2104-2119. doi: 10.1016/j.ejca.2015.08.001. Epub 2015 Sep 26. Eur J Cancer. 2015. PMID: 26421815
Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5).
Mounier M, Bossard N, Remontet L, Belot A, Minicozzi P, De Angelis R, Capocaccia R, Iwaz J, Monnereau A, Troussard X, Sant M, Maynadié M, Giorgi R; EUROCARE-5 Working Group; CENSUR Working Survival Group. Mounier M, et al. Lancet Haematol. 2015 Nov;2(11):e481-91. doi: 10.1016/S2352-3026(15)00155-6. Epub 2015 Oct 23. Lancet Haematol. 2015. PMID: 26686258
33 results